Official announcements
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 03.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on 04.06.2014 and asked for a stock check of the affected batches.
Recall
|
Medicines
|
04/06/2014
The parallel distributor informed its supplied customers on June 4, 2014 and asked for a stock check of the affected batches.
Safety warnings
|
messages in brief
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Safety warnings
|
messages in brief
|
30/05/2014
The BASG dissociates itself from statements on the homepage of the manufacturer of the unapproved drug "Reniale
Recall
|
Medicines
|
26/05/2014
In a letter dated May 26, 2014, the marketing authorization holder informed its customers that the degree of discoloration of batch 2G605A is just outside the permitted limit and the impurities are elevated. For batch 2M631A, although the degree of…
Recall
|
Medicines
|
21/05/2014
The marketing authorization holder has informed its supplied customers by letter dated 21.05.2014 that the above batch is being recalled as a precautionary measure due to possible particles.
Safety warnings
|
messages in brief
|
30/04/2014
European Commission orders withdrawal of approval for metoclopramide-containing medicines in drop form with a concentration higher than 1 mg/ml.
Safety warnings
|
Blood & Tissue
|
30/04/2014
The epidemic of Ebola virus disease (EVD) in West Africa in 2014 has increased the risk of Ebola virus transmissionvia donated blood and blood components, cells, tissues and organs(substances of human origin -SoHO).
Recall
|
Medicines
|
29/04/2014
The marketing authorization holder informed its supplied customers by letter dated April 24, 2014, that due to the implementing decision C(2013)9846 in the context of the European risk assessment procedure according to Article 31 of Directive…